“Immunogenicity and Safety of Cervarix HPV-16 18 AS04-Adjuvant Vaccine Against HPV Induced Cervical Cancer in Women (15+ Years)”. UCC Student Medical Journal, vol. 3, Oct. 2024, pp. 50-61, https://doi.org/10.33178/SMJ.2023.1.5.